PATENT CLAIM ANALYSIS

Application Number: 15753865
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-05
Patent Classification: ["514", "04400A"]

Abstract:
Provided herein are methods for the treatment of poly-cystic kidney disease, including autosomal dominant polycystic kidney disease, using modified oligonucleotides targeted to miR-17.

Claim (Index 10):
The method of  claim 1 , wherein the subject has hypertension.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 88.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14048827', '14872564', '15380629', '13811423', '14334872']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8235733029464762
- 35 USC 102 Novelty (BERT): 0.5403560987683986
- Combined Prediction Score: 0.7952515825286685
- Mean Citation Score: 364.996002
- Max Citation Score: 393.703
- Similarity Product: 256.74021353703733

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test